Lir
2 known investors
Lir develops AI models to design and optimize adeno-associated viral (AAV) vectors for gene therapies, using its nAAVigator platform and an integrated lab-in-the-loop that pairs high-throughput assays with AI. Its work targets improved vector efficiency, tissue targeting, and antibody evasion to make gene therapies safer and more effective.
Investors · 2
Frequently asked questions
- What does Lir do?
- Lir develops AI models to design and optimize adeno-associated viral (AAV) vectors for gene therapies, using its nAAVigator platform and an integrated lab-in-the-loop that pairs high-throughput assays with AI. Its work targets improved vector efficiency, tissue targeting, and antibody evasion to make gene therapies safer and more effective.
- Who are Lir's investors?
- Lir's investors include Amino Collective, Fly Ventures.